Interview 20 Mar 2025 AI meets biotech: Bullfrog AI’s CEO on the TechBio boom Find out about how TechBios are changing the industry by leveraging AI and partnering with biotech in our interview with Bullfrog AI’s CEO. March 20, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 17 Mar 2025 How biotechs are using AI to rescue failed drugs Discover how biotech companies like Ignota Labs and BioXcel Therapeutics are using AI to rescue failed drugs. March 17, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Reports Produced by Inpart 3 Mar 2025R&D trends: Biotech assets & discovery platforms Inpart’s latest report provides access to the most promising biotech assets and discovery platforms, shedding light on the latest trends in biotech R&D. March 3, 2025 Share WhatsApp Twitter Linkedin Email Produced by Inpart
Sponsored by Collaborative Drug Discovery Inc. 25 Feb 2025 How a virtual company leveraged data to accelerate drug development for neurodegenerative diseases Find out how the virtual biotech company Libra Therapeutics leveraged data to accelerate drug development for neurodegenerative diseases. February 25, 2025 - 9 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Sponsored by Cytel 18 Feb 2025 Why the right software is key to efficient trial design Facing delays and inefficiencies in clinical trial design? Learn how the right software can solve key challenges and improve outcomes. February 18, 2025 - 7 minutesmins - By Jennifer Tsang Share WhatsApp Twitter Linkedin Email
News and Trends 29 Nov 2024 Trump’s healthcare picks: Who they are and what they mean for the biopharma industry Trump’s nominees for top healthcare roles have sparked significant debate. So, what do their appointments signal for the future of healthcare in the U.S.? November 29, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 22 Nov 2024 Can AlphaFold3’s open-source platform revolutionize the way we discover drugs? Find out how Google DeepMind’s AlphaFold3 platform could help scientists revolutionize the field of drug discovery. November 22, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 21 Aug 2024 The promise of antisense oligonucleotides in precision medicine Find out all about antisense oligonucleotides, which have gained a lot of popularity in recent years and could treat numerous diseases. August 21, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 2 Aug 2024Rebroadcast: How does AI assist drug discovery? Listen to our podcast to discover how AI is revolutionizing drug discovery by tackling “undruggable” targets like KRAS. August 2, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 10 Jul 2024 Biotech’s battle against skeletal dysplasia: Ray of hope for children with rare genetic disorder As treatments for skeletal dysplasia are intended to alleviate painful symptoms, two drugs are battling out in the clinic to prove their effectiveness. July 10, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 13 Mar 2024 From LSD to healing minds: Where are we standing in psychedelic drug development? Delve into the growing sector of psychedelic drug development to find out where we are coming from, and where we are standing in the field. March 13, 2024 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 21 Feb 2024 Cytokine release syndrome: how pharma is tackling a 21st century disease Explore the frontier of biotech’s battle against cytokine release syndrome (CRS), from historical setbacks to cutting-edge solutions. February 21, 2024 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email